Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 August 2021 | Story Evodia Mohonyane

Stand out in the global world of work by signing up for LinkedIn Learning now

Learning and growth at university (and in life) is a journey and a lifelong process. The University of the Free State is committed to your personal and professional development and is now proud to offer LinkedIn Learning to all Kovsie students, free of charge.

Why use LinkedIn Learning?

LinkedIn Learning lets you learn at your own pace. You can select courses relevant to your current or future interests in areas such as entrepreneurship, technology, and leadership. You can also pursue other passions — with courses on financial literacy, social media, even drawing and music theory, you will be able to grow and develop in the areas you care about, both within and outside your degree.

Sign up and start your journey to learning skills that will get you a step closer to enterprising your degree and standing out in a global world of work.

Getting started

You will receive an activation email from the UFS via LinkedIn Learning. Don’t delete it! You must activate your LinkedIn Learning account using this activation email. You will have the option to connect through your personal LinkedIn profile (recommended) or activate your account using your ufs4life email.
  • Once you’re in, browse around for your UFS recommended courses
  • Take a course, learn something new, and apply it in your day-to-day life

Help is available!

If you run into issues with logging in, contact us. For technical issues once you are up and running, you have the option to click for help throughout the system, with access to LinkedIn Learning's FAQs, as well as the ability to connect via email, live chat, or phone.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept